Articles Referencing OMER

Omeros' OMS721 Files for Orphan Drug Status - Analyst Blog

4/18/2013, 5:11 pm from Zacks.com in Investing, Business, Stocks

Omeros Corporation ( OMER ) recently announced that the company has filed an Application for Orphan Drug Designation with the US Food and Drug Administration (FDA) for its candidate OMS721.... Read >>

Omeros Progresses with OMS824 - Analyst Blog

3/28/2013, 7:26 pm from Zacks.com in Investing, Business, Stocks

Omeros Corporation ( OMER ) recently announced positive results from the multiple-ascending-dose (MAD) section of the company's phase I study on OMS824. We note that OMS824 is the lead... Read >>

Safety Data on Omeros' OMS302 - Analyst Blog

1/23/2013, 5:14 pm from Zacks.com in Investing, Business, Stocks

Omeros Corporation ( OMER ) recently announced that it successfully completed the 90-day safety database lock for the second of its two phase III studies on OMS302. OMS302 is being... Read >>

Mixed Trial Results from Omeros - Analyst Blog

1/2/2013, 6:05 pm from Zacks.com in Investing, Business, Stocks

Omeros Corporation ( OMER ) recently reported mixed results from its first pivotal phase III study that was being conducted with OMS103HP in patients undergoing arthroscopic partial... Read >>

Pre-Market Most Active for Jun 27, 2012 : ERIC, AMRN, BAC, FB, ABB, JNJ, TKC, NOK, OMER, ARNA, NVO, ZNGA

6/27/2012, 8:39 am from NASDAQ.com News in News Headlines, Pre-market Most Active

The NASDAQ 100 Pre-Market Indicator is up 2.52 to 2,552.36. The total Pre-Market volume is currently 4,904,234 shares traded. The following are the most active stocks for the pre-market... Read >>